STAT

Sexual harassment allegations against Sam Isaly ripple through finance world

A high-value client of Sam Isaly's firm, OrbiMed, is reviewing its relationship with the fund in the wake of sexual harassment allegations first published in STAT.

As sexual harassment allegations against hedge fund titan Sam Isaly echo around Wall Street, one of his firm’s multibillion-dollar clients is reviewing its relationship with the fund, and Isaly has been removed from the agenda of an upcoming investor conference.

Isaly, the 72-year-old founder and managing partner of OrbiMed Advisors, for years sexually harassed and demeaned female employees, six former OrbiMed employees have told STAT. Isaly has denied the allegations.

Eaton Vance, an investment firm with more than $400 billion on Tuesday evening. The firm pays OrbiMed for investment advice.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.

Related Books & Audiobooks